BTMD - NASDAQ

biote Corp.

biote Corp.

BTMDยทNASDAQ

$2.11

+5.5%
HealthcareMedical - Care Facilities

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$93.07M
EPS0.8600
P/E Ratio2.45
Earnings Date08/05/2026
biote Corp.

biote Corp. Fair Value Envelope

BTMD ยท NASDAQ

Our analysis suggests that BTMD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $2.11, this represents a potential HIDDEN relative to our calculated worth for biote Corp..

HIDDEN
Intrinsic Value
Current Price: $2.11

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value$106.4M
+ Cash & Equivalents$24.1M
Firm Value$130.5M
- Debt$109.9M
Equity Value$20.6M
/ Shares Outstanding47,851,304B
DCF Value$0
OVERVALUED BY 80%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
$27.4M
$21.3M
$16.5M
$12.9M
$10.0M
$7.8M
$6.0M
$4.7M
$3.7M
$2.8M
Maintenance CapEx
-$779.9K
-$606.4K
-$471.5K
-$366.6K
-$285.1K
-$221.6K
-$172.3K
-$134.0K
-$104.2K
-$81.0K
Owner Earnings
$26.6M
$20.7M
$16.1M
$12.5M
$9.7M
$7.6M
$5.9M
$4.6M
$3.6M
$2.8M
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
$24.6M
$17.7M
$12.8M
$9.2M
$6.6M
$4.8M
$3.4M
$2.5M
$1.8M
$1.3M
Terminal Value represents 20.4% of Enterprise Value

Related Guides

Blog Categories

Continue your BTMD research with focused valuation guides.

DCF Modeling

Improve assumptions for intrinsic value accuracy.

Forecasting

Calibrate growth paths and terminal value behavior.

WACC

Refine discount-rate logic for valuation quality.

Cost of Capital

Match risk profile to expected return assumptions.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.